Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Chronic heart failure: a disease of the brain.

Singh RB, Hristova K, Fedacko J, El-Kilany G, Cornelissen G.

Heart Fail Rev. 2019 Mar;24(2):301-307. doi: 10.1007/s10741-018-9747-3. Review.

PMID:
30341700
2.

Coenzyme Q10 Modulates Remodeling Possibly by Decreasing Angiotensin-Converting Enzyme in Patients with Acute Coronary Syndrome.

Singh RB, Fedacko J, Mojto V, Pella D.

Antioxidants (Basel). 2018 Jul 25;7(8). pii: E99. doi: 10.3390/antiox7080099.

3.

Serum Uric Acid in Roma and Non-Roma-Its Correlation with Metabolic Syndrome and Other Variables.

Petrikova J, Janicko M, Fedacko J, Drazilova S, Madarasova Geckova A, Marekova M, Pella D, Jarcuska P.

Int J Environ Res Public Health. 2018 Jul 4;15(7). pii: E1412. doi: 10.3390/ijerph15071412.

4.

Age-adjusted Mortality Rates of Neoplasms and Circulatory System Diseases and Their Demographic Factors in Slovak Regions during 1996-2013.

Pella D, Fedačko J, Rajnoha R, Gavurová B, Koróny S.

Cent Eur J Public Health. 2017 Dec;25 Suppl 2:S86-S93. doi: 10.21101/cejph.a5056.

5.
6.

Regional disparities in medical equipment distribution in the Slovak Republic - a platform for a health policy regulatory mechanism.

Gavurová B, Kováč V, Fedačko J.

Health Econ Rev. 2017 Nov 9;7(1):39. doi: 10.1186/s13561-017-0176-0.

7.

Elevated Circulating PCSK9 Concentrations Predict Subclinical Atherosclerotic Changes in Low Risk Obese and Non-Obese Patients.

Tóth Š, Fedačko J, Pekárová T, Hertelyová Z, Katz M, Mughees A, Kuzma J, Štefanič P, Kopolovets I, Pella D.

Cardiol Ther. 2017 Dec;6(2):281-289. doi: 10.1007/s40119-017-0092-8. Epub 2017 Jun 16.

8.

Rare Presentation of Left Lower Lobe Pulmonary Artery Dissection.

Hako R, Fedačko J, Tóth Š, Morochovič R, Kristian P, Pekárová T, Tuomainen P, Pella D.

Case Rep Med. 2017;2017:2760535. doi: 10.1155/2017/2760535. Epub 2017 Jan 5.

9.

Extended consensus on blood pressure variability beyond blood pressure for management of hypertension.

Singh RB, Hristova K, Bjørklund G, Fedacko J, Chirumbolo S, Pella D.

J Am Soc Hypertens. 2017 Jan;11(1):6-9. doi: 10.1016/j.jash.2016.11.005. Epub 2016 Nov 25. No abstract available.

PMID:
28040405
10.

Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies.

Di Nisio M, Vedovati MC, Riera-Mestre A, Prins MH, Mueller K, Cohen AT, Wells PS, Beyer-Westendorf J, Prandoni P, Bounameaux H, Kubitza D, Schneider J, Pisters R, Fedacko J, Fontes-Carvalho R, Lensing AW.

Thromb Haemost. 2016 Sep 27;116(4):739-46. doi: 10.1160/TH16-02-0087. Epub 2016 Aug 18.

PMID:
27535349
11.

Pleiotropic effects of statins in the diseases of the liver.

Janicko M, Drazilova S, Pella D, Fedacko J, Jarcuska P.

World J Gastroenterol. 2016 Jul 21;22(27):6201-13. doi: 10.3748/wjg.v22.i27.6201. Review.

12.

Association between hepatitis B and metabolic syndrome: Current state of the art.

Jarcuska P, Drazilova S, Fedacko J, Pella D, Janicko M.

World J Gastroenterol. 2016 Jan 7;22(1):155-64. doi: 10.3748/wjg.v22.i1.155. Review.

13.

Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device.

Jedlickova L, Merkovska L, Jackova L, Janicko M, Fedacko J, Novakova B, Chmelarova A, Majernik J, Pella D.

Adv Ther. 2015 Oct;32(10):962-70. doi: 10.1007/s12325-015-0253-x. Epub 2015 Nov 2.

PMID:
26525390
14.

Redefining the alanine aminotransferase upper limit of normal improves the prediction of metabolic syndrome risk.

Janičko M, Veselíny E, Orenčák R, Husťak R, Fedačko J, Dražilová S, Madarasová-Gecková A, Mareková M, Pella D, Kristián P, Rác M, Jarčuška P; HepaMeta Study Group.

Eur J Gastroenterol Hepatol. 2015 Apr;27(4):405-11. doi: 10.1097/MEG.0000000000000297.

PMID:
25874513
15.

Inflammatory mediators in chronic heart failure in North India.

Fedacko J, Singh RB, Gupta A, Hristova K, Toda E, Kumar A, Saxena M, Baby A, Singh R, Toru T, Wilson DW.

Acta Cardiol. 2014 Aug;69(4):391-8.

PMID:
25181914
16.

Clinical and biochemical determinants of metabolic syndrome among Roma and non-Roma subjects in the eastern part of Slovakia.

Fedacko J, Pella D, Jarcuska P, Siegfried L, Janicko M, Veselíny E, Sabol F, Jarcuska P, Mareková M, Gecková AM, Pazinka P, Jankajová M, Kmec J, Babcák M, Kalanin P, Drazilová S; HepaMeta Team.

Cent Eur J Public Health. 2014 Mar;22 Suppl:S75-80.

17.

Prevalence of cardiovascular risk factors in relation to metabolic syndrome in the Roma population compared with the non-Roma population in the eastern part of Slovakia.

Fedacko J, Pella D, Jarcuska P, Siegfried L, Janicko M, Veselíny E, Pella J, Sabol F, Jarcuska P, Mareková M, Gecková AM, Pazinka P, Jankajová M, Kmec J, Babcák M, Kalanin P, Drazilová S, Babinská I, Cecetková B; HepaMeta Team.

Cent Eur J Public Health. 2014 Mar;22 Suppl:S69-74.

18.

High hepatitis B and low hepatitis C prevalence in Roma population in eastern Slovakia.

Veselíny E, Janicko M, Drazilová S, Siegfried L, Pastvová L, Schréter I, Kristian P, Viág L, Jarcuska P, Valková I, Cáriková K, Senajová G, Fedacko J, Pella D, Mareková M, Gecková AM, Jarcuska P; HepaMeta Team.

Cent Eur J Public Health. 2014 Mar;22 Suppl:S51-6.

19.

Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study.

Jarcuska P, Janicko M, Drazilová S, Senajová G, Veselíny E, Fedacko J, Siegfried L, Kristian P, Tkác M Jr, Pella D, Mareková M, Gecková AM, Jarcuska P; HepaMeta Team.

Cent Eur J Public Health. 2014 Mar;22 Suppl:S43-50.

20.

Association between metabolic syndrome and hepatitis B virus infection in the Roma population in eastern Slovakia: a population-based study.

Janicko M, Senajová G, Drazilová S, Veselíny E, Fedacko J, Siegfried L, Kristian P, Virág L, Pella D, Mareková M, Gecková AM, Kalanin P, Jarcuska P, Halánová M; HepaMeta Team.

Cent Eur J Public Health. 2014 Mar;22 Suppl:S37-42.

Supplemental Content

Loading ...
Support Center